Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine
about
Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 betaDevelopment of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulusDoes biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax?Site-directed mutagenesis of the catalytic residues Asp-52 and Glu-35 of chicken egg white lysozyme.Plasmodium vivax malaria vaccines: why are we where we are?Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat regionLife-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.Quantitative evaluation of the chicken lysozyme epitope in the HyHEL-10 Fab complex: free energies and kinetics.Synthetic peptide vaccine confers protection against murine malaria.Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes.Plasmodium vivax: who cares?A Ca(2+)-binding chimera of human lysozyme and bovine alpha-lactalbumin that can form a molten globule.An update on candidate malaria vaccines.Antibody response of humans to the circumsporozoite protein of Plasmodium vivax.Identification of a T-cell epitope on the circumsporozoite protein of Plasmodium vivax.Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity.Production of a malaria transmission-blocking protein from recombinant yeast.Choice of cellular protein expression system.Fermentation of a yeast producing A. niger glucose oxidase: scale-up, purification and characterization of the recombinant enzyme.
P2860
Q24563285-32C374CA-7E98-44F3-88AD-E02DE426BC0CQ30635427-9F975A6F-5899-4C3D-B310-CA7F55C36E3CQ33662908-D0595BF0-99AD-4288-AE2E-9718FA0203BCQ33828274-677B3A45-0221-42D6-B0BB-E545B7CBC3B2Q34170071-A2507FE8-3A26-4D66-B041-822C1B4CC083Q34350954-0BAC113B-C444-4506-AAD7-2FB87BA790D5Q35554701-2D089B88-4E89-453D-92CD-AA0CB7D47F81Q35689495-3A504E7C-AAD2-4FA2-86D0-D9A8AA6C080EQ36281312-0D73AA5B-B6FE-4789-BF8B-CE87913A9690Q36357591-49A2A829-AECE-4DA8-8A42-53F42BF500F9Q36362740-8E854C3A-FDA0-42C1-96EB-5B1ADF24B027Q37018632-3EBA8F69-CA88-428B-B0B1-4C3F3A7793CFQ38295610-0D927983-30F3-4A0B-96A7-7C03BAD837BFQ38635546-C66D04F1-6C83-4285-B340-78ACD8AC4A44Q40151464-4032DAFB-1878-41C7-B190-8F76B42E220CQ40153499-9016C122-CA6C-4E80-802F-CBCCA4A090E4Q43652608-276F0E22-F2A3-4671-9BBE-945942558190Q44173124-27581799-91D2-42CF-A4F9-2538A26305F7Q45966460-421C1E4A-0FA1-4417-8214-DADC523AF529Q53859821-D6E12A24-757F-444C-883A-C4826C0F8153
P2860
Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@ast
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@en
type
label
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@ast
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@en
prefLabel
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@ast
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@en
P2093
P2860
P356
P1476
Expression in yeast of a Plasm ...... use in a human malaria vaccine
@en
P2093
P2860
P304
P356
10.1084/JEM.165.4.1160
P407
P577
1987-04-01T00:00:00Z